Inhibition of viruses

Details Inhibition of viruses Inhibition of viruses

2006-05-23

2006-05-23

Wang, Shengjun (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S042000, C514S043000, C514S046000, C514S047000, C514S048000

Reexamination Certificate

active

07049303

ABSTRACT:
Disclosed is a pharmaceutical composition comprising a ribonucleoside analogue in accordance with general formula I or II as herein defined, in admixture with a physiologically acceptable excipient diluent or carrier.

REFERENCES:
patent: 6063628 (2000-05-01), Loeb et al.
patent: 0 352 248 (1990-01-01), None
patent: WO 90/06319 (1990-06-01), None
patent: WO 96/18398 (1996-06-01), None
patent: WO 96/40164 (1996-12-01), None
patent: WO 98/16184 (1998-04-01), None
patent: WO 98/18324 (1998-05-01), None
patent: WO 99/43691 (1999-09-01), None
patent: WO 01/19360 (2001-03-01), None
patent: WO 01/45691 (2001-06-01), None
Clercq et al., Antimicrobial Agents and Chemotherapy, 29(3):482-487 (Mar. 1986).
Tiwari et al., Nucleosides, Nucleotides & Nucleic Acids, 20(4-7):743-746 (2001).

Affiliated with

Also associated with

Rating

Inhibition of viruses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of viruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of viruses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3649965